Literature DB >> 25781673

Hypothalamic obesity in children: pathophysiology to clinical management.

Belma Haliloglu, Abdullah Bereket.   

Abstract

Hypothalamic obesity (HyOb) is a complex neuroendocrine disorder caused by damage to the hypothalamus, which results in disruption of energy regulation. The key hypothalamic areas of energy regulation are the ARC (arcuate nucleus), the VMH (ventromedial hypothalamus), the PVN (paraventriculer nuclei) and the LHA (lateral hypothalamic area). These pathways can be disrupted mechanically by hypothalamic tumors, neurosurgery, inflammatory disorders, radiotherapy and trauma or functionally as such seen in genetic diseases. Rapid weight gain and severe obesity are the most striking features of HyOb and caused by hyperphagia, reduced basal metabolic rate (BMR) and decreased physical activity. HyOb is usually unresponsive to diet and exercise. Although, GLP-1 and its anologs seem to be a new agent, there is still no curative treatment. Thus, prevention is of prime importance and the clinicians should be alert and vigilant in patients at risk for development of HyOb.

Entities:  

Mesh:

Year:  2015        PMID: 25781673     DOI: 10.1515/jpem-2014-0512

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  10 in total

Review 1.  Risk-adapted, long-term management in childhood-onset craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

2.  Novel predictive scoring system for morbid hypothalamic obesity in patients with pediatric craniopharyngioma.

Authors:  Mohammed A Fouda; David Zurakowski; R Michael Scott; Karen J Marcus; Peter E Manley; Nicole J Ullrich; Laurie E Cohen; Liliana C Goumnerova
Journal:  Childs Nerv Syst       Date:  2020-09-04       Impact factor: 1.475

3.  Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series.

Authors:  Christian Denzer; Friederike Denzer; Belinda S Lennerz; Heike Vollbach; Robert H Lustig; Martin Wabitsch
Journal:  Obes Facts       Date:  2019-03-07       Impact factor: 3.942

Review 4.  Late endocrine effects of childhood cancer.

Authors:  Susan R Rose; Vincent E Horne; Jonathan Howell; Sarah A Lawson; Meilan M Rutter; Gylynthia E Trotman; Sarah D Corathers
Journal:  Nat Rev Endocrinol       Date:  2016-04-01       Impact factor: 43.330

5.  Hypothalamic Obesity: 4 Years of the International Registry of Hypothalamic Obesity Disorders.

Authors:  Susan R Rose; Vincent E Horne; Nathan Bingham; Todd Jenkins; Jennifer Black; Thomas Inge
Journal:  Obesity (Silver Spring)       Date:  2018-10-08       Impact factor: 5.002

6.  Atypical major depressive episode as initial presentation of intracranial germinoma in a male adolescent.

Authors:  Yi-Ting Chen; Kuan-Pin Su; Jane Pei-Chen Chang
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-21       Impact factor: 2.570

7.  Dextroamphetamine Treatment in Children With Hypothalamic Obesity.

Authors:  Jiska van Schaik; Mila S Welling; Corjan J de Groot; Judith P van Eck; Alicia Juriaans; Marcella Burghard; Sebastianus B J Oude Ophuis; Boudewijn Bakker; Wim J E Tissing; Antoinette Y N Schouten-van Meeteren; Erica L T van den Akker; Hanneke M van Santen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-09       Impact factor: 5.555

8.  Transition From Diencephalic Syndrome to Hypothalamic Obesity in Children With Suprasellar Low Grade Glioma: A Case Series.

Authors:  Ichelle M A A van Roessel; Antoinette Y N Schouten-van Meeteren; Lisethe Meijer; Eelco W Hoving; Boudewijn Bakker; Hanneke M van Santen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-06       Impact factor: 6.055

Review 9.  Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity.

Authors:  Hermann L Müller
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-02       Impact factor: 3.243

10.  Hypothalamic injury patterns after resection of craniopharyngiomas and correlation to tumor origin: A study based on endoscopic observation.

Authors:  Le Yang; ShenHao Xie; Bin Tang; Xiao Wu; ZhiGao Tong; Chao Fang; Han Ding; YouYuan Bao; SuYue Zheng; Tao Hong
Journal:  Cancer Med       Date:  2020-11-03       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.